Tiger Brokers

  • Markets
    • Quotes
    • 24/7 News
  • Products
    • Cash Boost Account
    • Options
    • China A-shares
    • HK Stocks
    • Fixed Coupon Notes
    • US Stocks
    • Funds
    • US Treasury
    • Singapore Stocks
    • Futures
    • Tiger BOSS Debit Card
    • Tiger Vault
  • Features
    • Auto-invest
    • Invest with CPF/SRS
    • Learn
    • US Fractional Shares
  • TigerAI
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Statement
      • Statement
      • Dividends
  • Institution
    • Tiger Fund Management
    • Institution Service
      • Wealth and asset manager
      • Proprietary trading institutions
      • Introducing brokers
      • Third-party service provider
    • Tiger Open Platform
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

Senti Biosciences, Inc.

2.25
+0.17008.17%
Volume:753.56K
Turnover:1.63M
Market Cap:58.86M
PE:-0.42
High:2.38
Open:2.14
Low:1.80
Close:2.08
52wk High:16.94
52wk Low:1.26
Shares:26.16M
Float Shares:9.58M
Volume Ratio:1.28
T/O Rate:7.87%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.3578
EPS(LYR):-12.0350
ROE:-169.54%
ROA:-45.98%
PB:2.39
PE(LYR):-0.19

Loading ...

OverviewCompanyNewsFilings

Senti Biosciences Initiated at Buy by Laidlaw & Co.

Dow Jones
·
Jun 06

Press Release: Senti Bio Receives Additional $1.0 Million Tranche from California Institute for Regenerative Medicines (CIRM) Grant for Advancing Clinical Development of SENTI-202

Dow Jones
·
May 22

Senti Biosciences Inc. Reports Q1 2025 Financial Results: R&D Expenses Rise by $0.5M, Cash Holdings at $33.8M; Positive SENTI-202 Clinical Data Announced

Reuters
·
May 07

Senti Biosciences Q1 EPS $(1.41) Up From $(2.60) YoY

Benzinga
·
May 07

BRIEF-Senti Biosciences Q1 Net Income USD -14.112 Million

Reuters
·
May 07

Press Release: Senti Bio Reports First Quarter 2025 Financial Results and Provides a Corporate Update on Positive SENTI-202 Clinical Development

Dow Jones
·
May 07

Senti Biosciences Is Maintained at Buy by Chardan Capital

Dow Jones
·
May 02

Top Midday Decliners

MT Newswires Live
·
Apr 29

Senti Bio's SENTI-202, A First-In-Class Off-The-Shelf Logic Gated Selective CD33 OR FLT3 NOT EMCN CAR NK Cell Therapy, Demonstrates Positive Preliminary Clinical Results In The Treatment Of Pati

Reuters
·
Apr 28

Analyst Rate

Buy
Buy
100.00%
Hold
0.00%
Sell
0.00%

Corporate Actions

Financial Report Announcement
Aug 07, 2025 Pre-Market
Financial Report Announcement
May 06, 2025 Post Market
Financial Report Announcement
Mar 20, 2025 Post Market
Financial Report Announcement
Nov 14, 2024 Post Market
Financial Report Announcement
Aug 13, 2024 Post Market

Dividend History

no data

No relevant data is available

Valuation Analysis

-0.39
Current
-3.40
Sector Average
55.07%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-0.39
Maximum
-0.13
+1 STD
1.48
Minimum
-14.05
-1 STD
-8.28
Average
-3.40

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Fintech (Singapore) Pte. Ltd.
Email Address:
uservice@ttm.financial
User Agreement|Privacy Policy

Copyright © Tiger Fintech (Singapore) Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.